BAOJ Palliative Medicine

Bioaccent Online Publishing

About the Journal

The publication of BAOJ Palliative medicine focuses on offering resourceful solutions to people suffering from intractable pain. The publication provides quality care to those at the end of life, publishing psychosocial, medical, legal, and policy issues. This magazine on Palliative Medicine is the leading magazine. It publishes all aspects of care and aids patients suffering from intolerable pain.

The BAOJ Palliative medicine journal is the most sought-after periodical among professionals working in hospitals. It is also a handy journal for those doing research in palliative medicine. It is the most preferred journal among the audiences, such as:

  • Physicians
  • Pharmacists
  • Pediatricians
  • Trainee nurses
  • Physician assistants
  • Psychologists
  • Social workers
  • Pain medicine specialists

It is also the most preferred publication among others associated with the domain, such as the staff working in hospitals and nursing homes.

The reason for the extreme popularity of the publication is that it publishes only essential information related to Palliative Medicine. The main goal of the magazine is to improve the quality of life of patients and their families. It makes it to publish only the most recent developments in Palliative medicine and non-medicine treatments.

The journal of BAOJ Palliative medicine is known for providing information on all topics of Palliative medicine, including the most recent medical developments in the management of pain and its symptoms:

  • Model palliative care agendas
  • Evidence-based protocols
  • Reports on clinical cases
  • Spiritual and psychological aspects of end-of-life care
  • Guidance for professionals working with patients
  • Roundtable debates with leading specialists in Palliative medicine

People and medical professionals interested in knowing the latest news in palliative medicine can consider reading the BAOJ Palliative medicine publication. It publishes briefings in the Palliative Medicine domain, delivers only the latest scientific information covering all the areas of palliative medicine. The latest information that the palliative medicine journal publishes makes health care providers and clinicians keep themselves updated continuously.

Impact Factor: 1.4
  • Breakthrough Pain
  • Clinical Trials in Palliative Care
  • Communication Issues in Palliative Care
  • Comprehensive Care for Families
  • Cultural Issues in Palliative Care
  • Decision making at the end of Life
  • End of Life Health Care
  • Health Policy
  • Home Care
  • Hospice & Palliative Medicine
  • Illness & Pain Management
  • Medical Complications
  • Opioids
  • Outcomes Research in Palliative Care
  • Palliative Care in Geriatrics
  • Palliative Radiotherapy
  • Pediatric Palliative Care
  • Primary Healthcare
  • Rehabilitation
  • Spiritual Care
  • Symptom Management

Latest Articles

When I'm in Pain, I feel God is Testing Me: Differences in Middle Eastern and US Cancer Pain Experiences

Background: Cancer pain is prevalent and a huge source of patient suffering, yet, little is known about how this experience varies in different cultures with markedly different religious affiliations. ...

Randomised Controlled Trial of Fish Oil Supplement to Treat Cancer Cachexia

Patients with advanced cancer often suffer from cachexia, a debilitating and complex extreme weight loss syndrome which is also associated with shorter survival times. A pragmatic randomised controlled trial was conducted to determine whether an oral nutritional supplement containing ...

Latissimus Dorsi Myocutaneous Flap Approach for Treatment of Radiation-Induced Ulcer in Breast Cancer

In this paper we describe our clinical approach to the treatment of a radiation-induced ulcer resistant to conservative management, which represents an uncommon complication secondary to adjuvant radiation therapy for breast cancer. ...

Cancer Pain: Still a Relevant Issue

Pain is a common symptom in cancer patients: in the systematic review of Van der Beuken- van Everdingen and Coll. its prevalence ranged from 25% in newly diagnosed patients to 64% in patients with advanced cancer ...